EUA was filed earlier this month in the country and is the first international regulatory filing for Bharat Biotech's COVAXIN. Once approved by the local regulator, India is expected to donate some doses and also open the door for exports in commercial terms, as is being done currently by Western and Chinese vaccine manufacturers.
https://ift.tt/eA8V8J from https://ift.tt/2Mi6ufK
ليست هناك تعليقات:
إرسال تعليق